M1 muscarinic receptor is a key target of neuroprotection, neuroregeneration and memory recovery by i-Extract from Withania somnifera

  • 1.

    Alzheimer’s Association. 2018 Alzheimer’s disease facts and figures. Alzheimers Dement. 14, 367–429, https://doi.org/10.1016/j.jalz.2018.02.001 (2018).

  • 2.

    Maloney, B. & Lahiri, D. K. Epigenetics of dementia: understanding the disease as a transformation rather than a state. Lancet Neurol. 15, 760–774, https://doi.org/10.1016/s1474-4422(16)00065-x (2016).

  • 3.

    Selkoe, D. J. & Hardy, J. The amyloid hypothesis of Alzheimer’s disease at 25 years. EMBO Mol. Med. 8, 595–608, https://doi.org/10.15252/emmm.201606210 (2016).

  • 4.

    Jack, C. R. et al. Update on hypothetical model of Alzheimer’s disease biomarkers. Lancet Neurol. 12, 207–216, https://doi.org/10.1016/S1474-4422(12)70291-0 (2013).

  • 5.

    Bloom, G. S. Amyloid-beta and tau: the trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurol 71, 505–508, https://doi.org/10.1001/jamaneurol.2013.5847 (2014).

  • 6.

    Knobloch, M. &…

  • Read more…